Quantitation of translocator protein binding in human brain with the novel radioligand [18F]-FEPPA and positron emission tomography

被引:85
|
作者
Rusjan, Pablo M. [1 ]
Wilson, Alan A. [1 ,2 ]
Bloomfield, Peter M. [1 ]
Vitcu, Irina [1 ]
Meyer, Jeffrey H. [1 ,2 ]
Houle, Sylvain [1 ,2 ]
Mizrahi, Romina [1 ,2 ]
机构
[1] CAMH, PET Ctr, Toronto, ON M5T 1R8, Canada
[2] Univ Toronto, Dept Psychiat, Toronto, ON M5S 1A1, Canada
来源
基金
加拿大创新基金会;
关键词
inflammation; kinetic modeling; microglia; mitochondria; positron emission tomography; PERIPHERAL BENZODIAZEPINE-RECEPTOR; CEREBRAL BLOOD-FLOW; 18; KDA; PET; MICROGLIA; SITES; MODEL; LIGAND; VOLUME; VISUALIZATION;
D O I
10.1038/jcbfm.2011.55
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
This article describes the kinetic modeling of [F-18]-FEPPA binding to translocator protein 18 kDa in the human brain using high-resolution research tomograph (HRRT) positron emission tomography. Positron emission tomography scans were performed in 12 healthy volunteers for 180 minutes. A two-tissue compartment model (2-CM) provided, with no exception, better fits to the data than a one-tissue model. Estimates of total distribution volume (V-T), specific distribution volume (V-S), and binding potential (BPND) demonstrated very good identifiability (based on coefficient of variation (COV)) for all the regions of interest (ROIs) in the gray matter (COV V-T < 7%, COV V-S < 8%, COV BPND < 11%). Reduction of the length of the scan to 2 hours is feasible as V-S and V-T showed only a small bias (6% and 7.5%, respectively). Monte Carlo simulations showed that, even under conditions of a 500% increase in specific binding, the identifiability of V-T and V-S was still very good with COV < 10%, across high-uptake ROIs. The excellent identifiability of V-T values obtained from an unconstrained 2-CM with data from a 2-hour scan support the use of V-T as an appropriate and feasible outcome measure for [F-18]-FEPPA. Journal of Cerebral Blood Flow & Metabolism (2011) 31, 1807-1816; doi:10.1038/jcbfm.2011.55; published online 27 April 2011
引用
收藏
页码:1807 / 1816
页数:10
相关论文
共 50 条
  • [31] Positron emission tomography with [18F]-FDG in oncology
    Talbot, JN
    Petegnief, Y
    Kerrou, K
    Montravers, F
    Grahek, D
    Younsi, N
    [J]. NUCLEAR INSTRUMENTS & METHODS IN PHYSICS RESEARCH SECTION A-ACCELERATORS SPECTROMETERS DETECTORS AND ASSOCIATED EQUIPMENT, 2003, 504 (1-3): : 129 - 138
  • [32] Metabolism and Quantification of [18F] DPA-714, a New TSPO Positron Emission Tomography Radioligand
    Peyronneau, Marie-Anne
    Saba, Wadad
    Goutal, Sebastien
    Damont, Annelaure
    Dolle, Frederic
    Kassiou, Michael
    Bottlaender, Michel
    Valette, Heric
    [J]. DRUG METABOLISM AND DISPOSITION, 2013, 41 (01) : 122 - 131
  • [33] [18F]FEDAC translocator protein positron emission tomography-computed tomography for early detection of mitochondrial dysfunction secondary to myocardial ischemia
    Luo, Rui
    Wang, Lei
    Ye, Fei
    Wang, Yan-Rong
    Fang, Wei
    Zhang, Ming-Rong
    Wang, Feng
    [J]. ANNALS OF NUCLEAR MEDICINE, 2021, 35 (08) : 927 - 936
  • [34] Radionuclide impurities in [18F]F- and [18F]FDG for positron emission tomography
    Koehler, M.
    Degering, D.
    Zessin, J.
    Fuechtner, F.
    Konheiser, J.
    [J]. APPLIED RADIATION AND ISOTOPES, 2013, 81 : 268 - 271
  • [35] [18F]FEAC and [18F]FEDAC: Two novel positron emission tomography ligands for peripheral-type benzodiazepine receptor in the brain
    Yanamoto, Kazuhiko
    Kumata, Katsushi
    Yamasaki, Tomoteru
    Odawara, Chika
    Kawamura, Kazunori
    Yui, Joji
    Hatori, Akiko
    Suzuki, Kazutoshi
    Zhang, Ming-Rong
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (06) : 1707 - 1710
  • [36] Elevated [18F]fluorodopamine turnover in brain of patients with schizophrenia:: An [18F]fluorodopa/positron emission tomography study
    Kumakura, Yoshitaka
    Cumming, Paul
    Vernaleken, Ingo
    Buchholz, Hans-Georg
    Siessmeier, Thomas
    Heinz, Andreas
    Kienast, Thorsten
    Bartenstein, Peter
    Gruender, Gerhard
    [J]. JOURNAL OF NEUROSCIENCE, 2007, 27 (30): : 8080 - 8087
  • [37] PET Imaging of Lung Inflammation with [18F]FEDAC, a Radioligand for Translocator Protein (18 kDa)
    Hatori, Akiko
    Yui, Joji
    Yamasaki, Tomoteru
    Xie, Lin
    Kumata, Katsushi
    Fujinaga, Masayuki
    Yoshida, Yuichiro
    Ogawa, Masanao
    Nengaki, Nobuki
    Kawamura, Kazunori
    Fukumura, Toshimitsu
    Zhang, Ming-Rong
    [J]. PLOS ONE, 2012, 7 (09):
  • [38] In vitro and in vivo Human Metabolism of (S)-[18F]Fluspidine - A Radioligand for Imaging σ1 Receptors With Positron Emission Tomography (PET)
    Ludwig, Friedrich-Alexander
    Fischer, Steffen
    Houska, Richard
    Hoepping, Alexander
    Deuther-Conrad, Winnie
    Schepmann, Dirk
    Patt, Marianne
    Meyer, Philipp M.
    Hesse, Swen
    Becker, Georg-Alexander
    Zientek, Franziska Ruth
    Steinbach, Joerg
    Wuensch, Bernhard
    Sabri, Osama
    Brust, Peter
    [J]. FRONTIERS IN PHARMACOLOGY, 2019, 10
  • [39] In vitro and in vivo binding of neuroactive steroids to the sigma-1 receptor as measured with the positron emission tomography radioligand [18F]FPS
    Waterhouse, Rikki N.
    Chang, Raymond C.
    Atuehene, Nana
    Collier, Thomas Lee
    [J]. SYNAPSE, 2007, 61 (07) : 540 - 546
  • [40] Imaging Microglial/Macrophage Activation in Spinal Cords of Experimental Autoimmune Encephalomyelitis Rats by Positron Emission Tomography Using the Mitochondrial 18 kDa Translocator Protein Radioligand [18F]DPA-714
    Abourbeh, Galith
    Theze, Benoit
    Maroy, Renaud
    Dubois, Albertine
    Brulon, Vincent
    Fontyn, Yoann
    Dolle, Frederic
    Tavitian, Bertrand
    Boisgard, Raphael
    [J]. JOURNAL OF NEUROSCIENCE, 2012, 32 (17): : 5728 - 5736